Ying Mingang | Department Of Obstetrics And Gynecology Fujian Provincial Cancer Hospital
スポンサーリンク
概要
関連著者
-
Ying Mingang
Department of Obstetrics and Gynecology, Fujian Provincial cancer Hospital
-
Ying Mingang
Department Of Obstetrics And Gynecology Fujian Provincial Cancer Hospital
-
Xu Qin
Department Of Obstetrics And Gynecology Fujian Provincial Cancer Hospital
-
Xie Rong
Department of Obstetrics and Gynecology, Fujian Provincial cancer Hospital
-
Lin Yuzhen
Department of Obstetrics and Gynecology, Fujian Provincial cancer Hospital
-
Lin Yuzhen
Department Of Obstetrics And Gynecology Fujian Provincial Cancer Hospital
-
Xie Rong
Department Of Obstetrics And Gynecology Fujian Provincial Cancer Hospital
-
Xu Qin
Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine
-
Li Xiaoli
Laboratory Of Biochemistry And Molecular Biology Research Fujian Cancer Hospital Of Fujian Medical U
-
CHEN Gang
Department of Human Genetics and Public Health, Faculty of Medicine, Graduate School of Proteomics,
-
Chen Gang
Department Of Pathology Fujian Provincial Cancer Hospital
-
Xu Qin
Department Of Chemistry Key Lab Of Analytical Chemistry For Life Science Nanjing University
-
Lin Yan
Department of Obstetrics and Gynecology, Fujian Provincial cancer Hospital
-
Ye Yunbin
Department of immuo-oncology, Fujian Provincial cancer Hospital
-
Xu Qin
Dept. of Obstetrics and Gynecology, Fujian Provincial Cancer Hospital
-
Xie Rong
Dept. of Obstetrics and Gynecology, Fujian Provincial Cancer Hospital
-
Lin Yuzhen
Dept. of Obstetrics and Gynecology, Fujian Provincial Cancer Hospital
-
Sitruk-Ware Regine
Center for Biomedical Research, The Population Council
-
Ying Mingang
Dept. of Obstetrics and Gynecology, Fujian Provincial Cancer Hospital
-
Ye Yunbin
Department Of Immuo-oncology Fujian Provincial Cancer Hospital
-
CHEN Yan
Laboratory of Biochemistry and Molecular Biology Research, Fujian Cancer Hospital of Fujian Medical
-
CHEN YanSong
Laboratory of Biochemistry and Molecular Biology Research, Fujian Cancer Hospital of Fujian Medical
-
HU Minhua
Laboratory of Biochemistry and Molecular Biology Research, Fujian Cancer Hospital of Fujian Medical
-
LIN Yingying
Laboratory of Biochemistry and Molecular Biology Research, Fujian Cancer Hospital of Fujian Medical
-
CHEN Dedong
Laboratory of Biochemistry and Molecular Biology Research, Fujian Cancer Hospital of Fujian Medical
-
ZHANG Ming
Sino-Swed Molecular Bio-Medicine Research Institute
-
YUN Xia
Sino-Swed Molecular Bio-Medicine Research Institute
-
ZHOU Ji
Sino-Swed Molecular Bio-Medicine Research Institute
-
HE Ellen
Sino-Swed Molecular Bio-Medicine Research Institute
-
SKOG Sven
Sino-Swed Molecular Bio-Medicine Research Institute
-
Chen Yan
Laboratory Of Biochemistry And Molecular Biology Research Fujian Cancer Hospital Of Fujian Medical U
-
Ying Mingang
Department Of Surgery Fujian Cancer Hospital Of Fujian Medical University Teaching Hospital
-
Hu Minhua
Laboratory Of Biochemistry And Molecular Biology Research Fujian Cancer Hospital Of Fujian Medical U
-
Chen Dedong
Laboratory Of Biochemistry And Molecular Biology Research Fujian Cancer Hospital Of Fujian Medical U
-
Lin Yingying
Laboratory Of Biochemistry And Molecular Biology Research Fujian Cancer Hospital Of Fujian Medical U
-
Sitruk-ware Regine
Center For Biomedical Research The Population Council
-
Lin Yan
Department Of Biometry And Epidemiology Medical University Of South Carolina
-
Chen Gang
Department of Chemistry, Fudan University
-
Chen Gang
Department of Cardiology, Shanghai First People's Hospital, Medical College, Shanghai Jiaotong University
著作論文
- IS-34 Primary Malignant Melanoma Arising in an Ovarian Dermoid cyst(Group5 Oncology5,International Session)
- IS-46 Effects of PRM CDB-2914 on the induction of extracellular matrix metalloproteinase inducer (EMMPRIN)/CD147 in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells(Group6 Oncology3,International Session)
- Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings